Old Web
English
Sign In
Acemap
>
authorDetail
>
Lisa Dunkle
Lisa Dunkle
Schering-Plough
Immunology
Vicriviroc
CCR5 receptor antagonist
Medicine
Virology
4
Papers
114
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment-Experienced Subjects: 48-Week Results of the VICTOR-E1 Phase 2 Trial
2010
The Journal of Infectious Diseases
Jamal Suleiman
Barry S. Zingman
Ricardo Sobhie Diaz
José Valdez Madruga
Edwin DeJesus
Jihad Slim
Carmen Mak
E. S. Lee
Michael C. McCarthy
Lisa Dunkle
Sharon Walmsley
Show All
Source
Cite
Save
Citations (37)
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults.
2007
AIDS
Dirk Schürmann
Gerd Fätkenheuer
Jacques Reynes
Christian Michelet
François Raffi
Jan Van Lier
María Cáceres
Anther Keung
Angela Sansone-Parsons
Lisa Dunkle
Christian Hoffmann
Show All
Source
Cite
Save
Citations (73)
Compositions comprenant une combinaison d'antagonistes ccr5 et cxcr4
2006
Lisa Dunkle
Julie M. Strizki
Bahige M. Baroudy
Jayaram R. Tagat
Show All
Source
Cite
Save
Citations (0)
Vicriviroc Is a Novel, Potent CCR5 Inhibitor With Outstanding Pharmaceutic, Pharmacokinetic and PharmaCodynamic (PK/PD) Properties
2005
Retrovirology
Lisa Dunkle
Anther Keung
Angela Sansone
Julie M. Strizki
Show All
Source
Cite
Save
Citations (4)
1